ARK Genomic Revolution ETF
ARKGETF · Cboe BZX
$54.63
-$0.19 (-0.34%)
EOD Oct 29, 2026
Key facts
- Expense ratio
- 0.75%
- Dividend yield (TTM)
- 0.00%
- Distributions
- Annual
- Fund net assets (Jul 2026)
- $1.6B
- Stocks held
- 32
- Other positions
- 1
- Turnover (last fiscal year)
- 34%
- 52-week range
- $24.60 to $58.83
Top 10 holdings
All holdings59.1% of assets in ten stocks, as of Jul 31, 2026
| Company | Weight | Quality |
|---|---|---|
| 9.39% | 48 | |
| 7.73% | 40 | |
| 6.56% | 40 | |
| 6.29% | 40 | |
| 5.47% | 33 | |
| 5.14% | 10 | |
| 4.74% | 30 | |
| 4.74% | 68 | |
| 4.68% | 73 | |
| 4.30% | 57 |
Sector allocation
Share of the fund's assets
- Healthcare71.5%
- Industrials21.5%
- Technology6.6%
Scores of what it owns
Every holding's scoreEach holding's score, weighted by its size in the fund
3% of the fund's stock weight sits in companies with a Quality score above 75, 76% in companies below 50.
Where it invests
Stock weight by the company's home country
- United States90.1%
- Switzerland6.3%
- United Kingdom3.3%
Growth of $10,000
With and without the dividends reinvested
Dividend
Dividend historyARKG has not paid a dividend in the last twelve months; the last payment was ex-dividend Dec 29, 2021.
Average annual returns
Total return at net asset value, to Jul 31, 2026, as reported to the SEC
| 1 year | 5 years | 10 years |
|---|---|---|
| 61.72% | 14.38% | 8.33% |
Past returns say nothing certain about future ones.
ARKG questions
What does ARKG invest in?+
ARK Genomic Revolution ETF is an exchange-traded fund. Its largest holdings are 10x Genomics Inc. (9.39%), Twist Bioscience Corporation (7.73%), Tempus AI, Inc. (6.56%).
What is ARKG's expense ratio?+
0.75% a year, as stated in the fund's latest shareholder report filed with the SEC. On a $10,000 investment that is about $75.00 a year.
How good are the companies ARKG owns?+
Weighted by position size, the stocks in ARKG average a Quality score of 42 out of 100. 3% of the fund's stock weight sits in companies scoring above 75, 76% in companies below 50. The score is computed from each company's SEC filings; the methodology page lists every check.
Holdings: the fund's latest SEC Form N-PORT, as of Jul 31, 2026. Expense ratio, turnover and returns: the fund's shareholder report (SEC Form N-CSR) for the period to Jul 31, 2026. Net assets: SEC Form N-PORT. Quality scores: computed by Intrinsiqq from each company's SEC filings (methodology). Price: end of day Oct 29, 2026.